je.st
news
Biogen shares drop after report of death of patient while on Tecfidera
2014-10-22 23:10:33| Biotech - Topix.net
Biogen's Tecfidera was the biggest locally-developed drug to be approved in the U.S. in 2013. It's expected to make more than $4 billion in revenue in 2018.
Tags: on
while
report
death
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||